AU2001267541A1 - Vaccine composition - Google Patents
Vaccine compositionInfo
- Publication number
- AU2001267541A1 AU2001267541A1 AU2001267541A AU6754101A AU2001267541A1 AU 2001267541 A1 AU2001267541 A1 AU 2001267541A1 AU 2001267541 A AU2001267541 A AU 2001267541A AU 6754101 A AU6754101 A AU 6754101A AU 2001267541 A1 AU2001267541 A1 AU 2001267541A1
- Authority
- AU
- Australia
- Prior art keywords
- vaccine composition
- vaccine
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24161—Methods of inactivation or attenuation
- C12N2770/24164—Methods of inactivation or attenuation by serial passage
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00420112 | 2000-05-30 | ||
| EP00420112A EP1159969A1 (en) | 2000-05-30 | 2000-05-30 | Composition vaccinale |
| PCT/EP2001/006871 WO2001091790A1 (en) | 2000-05-30 | 2001-05-29 | Vaccine composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001267541A1 true AU2001267541A1 (en) | 2001-12-11 |
Family
ID=8174059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001267541A Abandoned AU2001267541A1 (en) | 2000-05-30 | 2001-05-29 | Vaccine composition |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1159969A1 (en) |
| KR (1) | KR20030007684A (en) |
| CN (1) | CN1188168C (en) |
| AU (1) | AU2001267541A1 (en) |
| BR (1) | BR0111223A (en) |
| MX (1) | MXPA02011654A (en) |
| WO (1) | WO2001091790A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2338508T (en) | 2002-05-03 | 2018-05-16 | The Government Of The Us Secretary Department Of Health And Human Services | A rden3/4delta 30(me), rden2/4delta30(me) or rden1/4delta30(me) recombinant chimeric dengue virus containing a 30 nucleotide deletion (delta30) in a section of the 3' untranslated region of dengue type 4 genome, wherein said 30 nucleotide deletion corresponds to the tl2 stem-loop structure |
| FR2903605A1 (en) | 2006-07-12 | 2008-01-18 | Sanofi Pasteur Sa | IMMUNIZATION METHOD AGAINST THE FOUR SEROTYPES OF DENGUE |
| FR2906724B1 (en) | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | METHOD OF IMMUNIZATION AGAINST THE 4 SEROTYPES OF DENGUE. |
| FR2909286B1 (en) | 2006-12-01 | 2012-06-08 | Sanofi Pasteur | IMMUNIZATION METHOD AGAINST THE 4 SEROTYPES OF DENGUE |
| CN102449172A (en) * | 2009-06-01 | 2012-05-09 | 伊维拉根公司 | Compositions and methods of administering vaccines against dengue virus |
| MY194650A (en) * | 2015-11-27 | 2022-12-09 | Km Biologics Co Ltd | Multivalent dengue vaccine composition comprising a mixture of attenuated dengue viruses from different serotypes |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996040933A1 (en) * | 1995-06-07 | 1996-12-19 | The Government Of The United States Of America, Represented By The Secretary Department Of Health And Human Services | Infectious dengue 2 virus pdk-53 as quadravalent vaccine |
| FR2761698B1 (en) * | 1997-04-04 | 1999-05-07 | Pasteur Merieux Serums Vacc | TITRATION METHOD OF A COMPLEX VIRAL COMPOSITION |
-
2000
- 2000-05-30 EP EP00420112A patent/EP1159969A1/en not_active Withdrawn
-
2001
- 2001-05-29 WO PCT/EP2001/006871 patent/WO2001091790A1/en not_active Ceased
- 2001-05-29 MX MXPA02011654A patent/MXPA02011654A/en unknown
- 2001-05-29 AU AU2001267541A patent/AU2001267541A1/en not_active Abandoned
- 2001-05-29 BR BR0111223-6A patent/BR0111223A/en not_active IP Right Cessation
- 2001-05-29 KR KR1020027015839A patent/KR20030007684A/en not_active Withdrawn
- 2001-05-29 CN CNB018104096A patent/CN1188168C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA02011654A (en) | 2003-03-27 |
| CN1431913A (en) | 2003-07-23 |
| KR20030007684A (en) | 2003-01-23 |
| WO2001091790A1 (en) | 2001-12-06 |
| CN1188168C (en) | 2005-02-09 |
| EP1159969A1 (en) | 2001-12-05 |
| BR0111223A (en) | 2003-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2002002700A0 (en) | Vaccine composition | |
| HUP0302117A3 (en) | Vaccine composition | |
| AU781269C (en) | Pharmaceutical compositions | |
| GB0020089D0 (en) | Vaccine Composition | |
| AU2001286233A1 (en) | Cement composition | |
| AU2001281887A1 (en) | Enamel composition | |
| AU2001250420A1 (en) | Pharmaceutical compositions | |
| AU2001274307A1 (en) | Pharmaceutical compositions | |
| AUPQ875700A0 (en) | Combination compositions | |
| AU2002214324A1 (en) | Medicinal compositions | |
| AU2001290239A1 (en) | Medicinal composition | |
| AU2001281965A1 (en) | Novel 6-phenylphenanthridines | |
| AU2001241098A1 (en) | Composition | |
| AU2001273919A1 (en) | Pharmaceutical compositions | |
| AU2001275201A1 (en) | Acne-treating composition | |
| AU4085201A (en) | Pharmaceutical composition | |
| AU2001267541A1 (en) | Vaccine composition | |
| AU2001287852A1 (en) | Composition | |
| AU2001235764A1 (en) | Compositions | |
| AU2001287732A1 (en) | Copolycarbonate-based composition | |
| AU2001278788A1 (en) | Oral composition | |
| AU3586401A (en) | Pharmaceutical composition | |
| AU2001262163A1 (en) | Composition | |
| AU2001282541A1 (en) | Medicinal compositions | |
| AU2001278487A1 (en) | Oral composition |